| Literature DB >> 32547429 |
Livia Colle1, Dize Hilviu1, Roberta Rossi2, Francesca Garbarini3, Carlotta Fossataro3.
Abstract
Self-harm is considered a pervasive problem in several psychopathologies, and especially in Borderline Personality Disorder (BPD). Self-harming behaviors may be enacted for many purposes for example to regulate emotions and to reduce dissociation. BPD patients often report dissociative episodes, which may be related to an altered body awareness, and in particular to an altered awareness of the sense of agency. The sense of agency draws in part upon perceptions of being in control of our bodies and our physical movements, of being able to act upon environments. In this study, we aim to investigate whether dissociative experiences of BPD patients may be linked to an altered sense of agency and whether self-injurious actions may, through strong sensorial stimulation, constitute a coping strategy for the reduction of the distress associated with these dissociative experiences. A group of 20 BPD patients, of whom 9 presented self-harming behaviors, took part in the study and were compared with an age-matched control group of 20 healthy individuals. Sense of agency was evaluated through the Sensory Attenuation paradigm. In this paradigm, in a comparison with externally generated sensations, the degree to which perceived intensity of self-generated sensations is reduced is considered an implicit measure of sense of agency. As we expected, we found a significant difference in the perceptions of the two groups. The attenuation effect appeared to be absent in the BPD group while it was present in the control group. However, further analysis revealed that those BPD patients who engaged in self-harming behaviors presented a degree of attenuation which was similar to that of the control group. These results confirm the hypothesis that self-injurious actions constitute a coping strategy for increasing the sense of agency. We finally discuss the correlation of these experimental results with some clinical self-evaluation measures assessing dissociation, anxiety, depression, and affective dysregulation.Entities:
Keywords: borderline personality disorder; dissociation; self-harming behaviors; sense of agency; sensory attenuation
Year: 2020 PMID: 32547429 PMCID: PMC7273851 DOI: 10.3389/fpsyt.2020.00449
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Pharmacological treatment.
| Pharmacological treatment* (Molecule, quantity in mg) | |||||||
|---|---|---|---|---|---|---|---|
| NSSI | Antipsychotic | SSRI | SNRI | Mood stabilizer | Benzodiazepine | ||
| Atypical | Typical | ||||||
| yes | quetiapine, 300 mg | sertraline, 50 mg | triazolam, | ||||
| past | fluoxetine, 10 mg | gabapentin, 100 mg | |||||
| yes | haloperidol, 10 mg | sertraline, 100 mg | lamotrigine, 25 mg | alprazolam, | |||
| past | aripiprazole, 30 mg | ||||||
| no | risperidone, 3 mg | duloxetine, | lithium, 900 mg | flurazepam, | |||
| no | lamotrigine, 300 mg, pregabalin 300 mg | lorazepam, 2 mg | |||||
| past | VASV, 1500 mg | diazepam, 20 mg | |||||
| no | quetiapine, 100 mg | sertraline, | lithium, 450 mg, | ||||
| yes | quetiapine, 450 mg | ||||||
| yes | gabapentin, 400 mg | ||||||
| yes | duloxetine, 60 mg | VASV, 500 mg | |||||
| no | VASV, 900 mg | lorazepam, 1 mg | |||||
| no | VASV, 800 mg | ||||||
| yes | paroxetine, 20 mg | delorazepam, 10 mg | |||||
| yes | lamotrigine, 200 mg | ||||||
| no | quetiapine, 100 mg | VASV, 500 mg | |||||
NSSI, non-suicidal self-injury; SSRI, Selective serotonin reuptake inhibitors; SNRI, Selective serotonin and noradrenaline reuptake inhibitors; VASV, valproic acid-sodium valproate.
*Patients 4 and 12 are not present in this list since they were excluded from the final sample because of recent changes in the pharmacological treatment and voluntary drop out of the test. Patients 7, 14, 17, and 21 are not present because they do not undergo any pharmacological treatment.
Figure 1Experimental conditions. Left panel shows the “self-generated stimulation” condition (light blue) in which participants had to press the button with their left hand to deliver the stimulus (depicted as the red lighting). Right panel shows the “other-generated stimulation” condition (orange) in which participants were asked to stay still while a co-experimenter pressed the button to deliver the stimulus. Note that, in this condition, participants were asked to observe experimenter’s action.
Figure 2Stimulation set-up. Three electrodes were attached on the subjects’ right hand: two of them with a positive polarity and the other one with negative polarity that was also the farthest electrode from the participant’s body. For each trial, only two electrodes were engaged: the one with negative polarity and one between the other two (chosen randomly).
Figure 3Within group analysis. Separately for each group, it is reported the significant difference between subjective ratings on the perceived painful stimuli during the two experimental conditions (i.e., self-generated stimulation in light blue and other-generated stimulation in orange). Note lower responses in self-generated compared to other-generated stimulation (i.e., sensory attenuation) in both CTRL and BPD+NSSI groups, while an opposite pattern was found in the BPD-NSSI group. Error bars indicate sem. Asterisk indicates the significant comparison (*p < .05; **p < .005).
Figure 4Between groups analysis. Significant differences in the sensory attenuation index between groups (CTRL in black; BPD-NSSI in gray, and BPD+NSSI in grey diagonal lines pattern). Error bars indicate sem. Asterisk indicates the significant comparison (** p < .005).
Figure 5Threshold level. Separately for each group, the intensity stimulation (mA) is reported. Error bars indicate sem. (CTRL in black; BPD-NSSI in gray, and BPD+NSSI in gray diagonal lines pattern).
Participants’ score on self-report questionnaires.
| Group scores (mean ± SD) | ||||
|---|---|---|---|---|
| Self-report questionnaires | CTRL | BPD-NSSI | BPD+NSSI | p |
| DES | 9.98 ± 6.27 | 12.96 ± 10.57 | 31.12 ± 15.76 | .0001 |
| ISAS - Intrapersonal | 10.71 ± 10.84 | 17 ± 7.92 | .239 | |
| ISAS - Interpersonal | 9.57 ± 14.75 | 8.43 ± 3.51 | .845 | |
| SCL-90-R | 1.59 ± 0.90 | 1.78 ± 0.79 | .665 | |
| DERS | 80.65 ± 28.59 | 101.90 ± 31.73 | 131.38 ± 21.25 | .0005 |
| BIS-11 | 58.75 ± 10.54 | 64 ± 9.41 | 70.63 ± 9.38 | .02 |
| BDI-II | 7.65 ± 8.87 | 16.78 ± 10.28 | 29.63 ± 16.74 | .0002 |
| STAI-T | 35.75 ± 11.74 | 47.57 ± 11.72 | 63.40 ± 13.65 | .0002 |
| STAI-S | 40.70 ± 12.79 | 45 ± 8.35 | 52.80 ± 10.89 | .12 |
DES, Dissociative Experiences Scale; ISAS, Inventory of statements about self-injury; SCL-90, Symptom Checklist-90-R; DERS, Difficulties in Emotion Regulation Scale; BIS-11, Barratt Impulsiveness Scale, version 11; BDI-II, Beck Depression Inventory II; STAI-Y, State-Trait Anxiety Inventory; Scores of the CTRL group for SCL-90-R are not present. SCL-90-R in fact evaluates the symptoms’ severity of the pathology.
A t-test was performed.